# A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery

> **NCT00902928** · PHASE2,PHASE3 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 1992 (actual)

## Conditions studied

- Venous Thromboembolism
- Arthroplasty, Replacement, Hip

## Interventions

- **DRUG:** YM150
- **DRUG:** enoxaparin

## Key facts

- **NCT ID:** NCT00902928
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-08
- **Target enrollment:** 1992 (ACTUAL)
- **Last updated:** 2015-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00902928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00902928, "A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00902928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*